Funded with $350 million from top-tier VCs and led by a veteran pharma CEO, a new obesity startup called Metsera has been quietly building plans to get multiple drugs into the clinic over the next two years, Endpoints News has exclusively learned.
Metsera’s CEO is Clive Meanwell, the former chief executive of The Medicines Company. The company was incorporated in 2022 by Population Health Partners, an investment firm started in 2020 by Meanwell and former Pfizer CEO Ian Read.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.